Clinical Trials Logo

Clinical Trial Summary

The effects of home noninvasive ventilation on renin-angiotensin system (RAS), kallikrein-kinin system (KKS) and cardiac remodeling in patients with chronic stable heart failure have not been reported. This project aims to clarify the efficacy and safety of home non-invasive ventilation in patients with chronic heart failure complicated with sleep-disordered breathing. First, patients with chronic stable heart failure were selected and monitored by polysomnography. Patients with sleep apnea hypopnea syndrome (SAHS, AHI≥15) were randomly divided into two groups: the treatment group was treated with non-invasive ventilator at home (≥5h/ night); The control group was only given routine treatment. After 6 months of follow-up, the effects of sleep disordered breathing and noninvasive ventilation on RAS, KKS, cardiac remodeling and function and cardiovascular adverse events in patients with chronic heart failure were evaluated. The results are helpful to further reveal the role of sleep disordered breathing in the occurrence and development of chronic heart failure, and provide a new diagnosis and treatment strategy for chronic heart failure.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05034549
Study type Interventional
Source Qilu Hospital of Shandong University
Contact
Status Recruiting
Phase N/A
Start date August 5, 2019
Completion date August 2023

See also
  Status Clinical Trial Phase
Terminated NCT03346278 - Text Message Intervention to Improve Cardiac Rehab Participation N/A
Completed NCT02696967 - A Study of CLR325 in Chronic Stable Heart Failure Patients. Phase 2
Recruiting NCT03834155 - Enhancing Cardiac Rehabilitation Through Behavioral Nudges N/A
Not yet recruiting NCT04507347 - Efficacy and Safety of TRC041266 in Patients With Heart Failure, LVEF ≥40%, Diastolic Dysfunction and Type 2 Diabetes Mellitus Phase 3
Completed NCT02204449 - Cardiac Rehabilitation Peer Mentorship N/A
Completed NCT00664222 - Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF) Phase 4
Completed NCT00663195 - Effects of Spironolactone on Matrix Metalloproteinases (MMPs) in Heart Failure Phase 4
Completed NCT00663494 - Matrix Metalloproteinase (MMP) in Heart Failure N/A
Recruiting NCT01065194 - Efficacy and Safety of Pulsed Infusions of Levosimendan in Outpatients With Advanced Heart Failure Phase 3